Mounjaro in India rose 60% in May from April, the first full month the popular weight loss/diabetes drug was available in the ...

Camurus and Lilly have entered a collaboration and license agreement, granting Lilly exclusive, worldwide rights to the ...

Eli Lilly and Camurus have entered into partnership worth up to $870m to develop long-acting therapies in cardiometabolic ...

Shares of Swedish drugmaker Camurus shot up 23% to 638.50 kronor yesterday on news of that it has entered a collaboration and license agreement with Eli Lilly, granting the US pharma major exclusive, ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

Eli Lilly is partnering with Camurus, a company with technology that extends how long an injectable drug lasts in the body, ...

Medical Devices & Diagnostics Analysts, along with Dr. Jolie Chang, Chief of Sleep Surgery Division at UCSF, discuss 2Q25 sleep medicine trends ...

Nordic stocks gained Wednesday, with the OMX Nordic 40 Index rising 1.3%. Camurus AB was the biggest leader among large stocks during the session, soaring 23.9%, and Thule Group AB gained 5.6%. Sinch ...

The deal, which could be worth up to $870 million overall, will give Lilly access to a delivery technology that may help ...